-
Je něco špatně v tomto záznamu ?
Podophyllotoxin Alleviates DSS-Induced Ulcerative Colitis via PI3K/AKT Pathway Activation
T. Li, X. Wang, J. Wang
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- fosfatidylinositol-3-kinasy * metabolismus MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- podofylotoxin * farmakologie terapeutické užití MeSH
- protoonkogenní proteiny c-akt * metabolismus MeSH
- signální transdukce účinky léků MeSH
- simulace molekulového dockingu MeSH
- síran dextranu toxicita MeSH
- ulcerózní kolitida * farmakoterapie chemicky indukované metabolismus patologie MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
This study systematically evaluated the therapeutic effects of podophyllotoxin in a DSS-induced mouse model of ulcerative colitis. A total of 374 podophyllotoxin-related targets were identified through database screening, and by intersecting them with 1,741 UC-related targets, 120 potential therapeutic targets were obtained. Subsequent GO and KEGG enrichment analyses revealed that these targets are primarily involved in biological processes such as the positive regulation of protein kinase B signaling, cellular response to lipopolysaccharide, and inflammatory responses, with significant enrichment in key pathways like the PI3K-Akt signaling pathway. Molecular docking results indicated that podophyllotoxin has strong binding activity with several targets related to inflammation and signal transduction. Animal experiments further validated the significant therapeutic effects of podophyllotoxin in the DSS-induced ulcerative colitis mouse model. Particularly at high doses, podophyllotoxin effectively alleviated ulcerative colitis symptoms, reduced pathological damage to colonic tissues, and enhanced intestinal barrier function. Additionally, podophyllotoxin significantly lowered the levels of inflammatory cytokines (TNF-?, IL-1?, IL-6) in the serum and colonic tissues of ulcerative colitis model mice and improved oxidative stress status. More importantly, podophyllotoxin effectively restored the impaired intestinal mucosal barrier function by enhancing the expression of tight junction proteins such as ZO-1 and occludin. Finally, the study revealed that podophyllotoxin may alleviate ulcerative colitis symptoms and promote colonic tissue repair by activating the PI3K/AKT signaling pathway. These findings provide strong experimental evidence for the potential use of podophyllotoxin as a therapeutic agent for ulcerative colitis and offer valuable insights for the future development of ulcerative colitis treatment strategies targeting the PI3K/AKT pathway. Key words: Podophyllotoxin, Ulcerative Colitis, Inflammation, PI3K/AKT.
Department of Emergency The Affiliated Hospital of Southwest Medical University Luzhou Sichuan China
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25017877
- 003
- CZ-PrNML
- 005
- 20251017095847.0
- 007
- ta
- 008
- 250814s2025 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935487 $2 doi
- 035 __
- $a (PubMed)40432443
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Li, T $u Department of Emergency, The Affiliated Hospital of Southwest Medical University. Luzhou, Sichuan, China. 411028555@qq.com
- 245 10
- $a Podophyllotoxin Alleviates DSS-Induced Ulcerative Colitis via PI3K/AKT Pathway Activation / $c T. Li, X. Wang, J. Wang
- 520 9_
- $a This study systematically evaluated the therapeutic effects of podophyllotoxin in a DSS-induced mouse model of ulcerative colitis. A total of 374 podophyllotoxin-related targets were identified through database screening, and by intersecting them with 1,741 UC-related targets, 120 potential therapeutic targets were obtained. Subsequent GO and KEGG enrichment analyses revealed that these targets are primarily involved in biological processes such as the positive regulation of protein kinase B signaling, cellular response to lipopolysaccharide, and inflammatory responses, with significant enrichment in key pathways like the PI3K-Akt signaling pathway. Molecular docking results indicated that podophyllotoxin has strong binding activity with several targets related to inflammation and signal transduction. Animal experiments further validated the significant therapeutic effects of podophyllotoxin in the DSS-induced ulcerative colitis mouse model. Particularly at high doses, podophyllotoxin effectively alleviated ulcerative colitis symptoms, reduced pathological damage to colonic tissues, and enhanced intestinal barrier function. Additionally, podophyllotoxin significantly lowered the levels of inflammatory cytokines (TNF-?, IL-1?, IL-6) in the serum and colonic tissues of ulcerative colitis model mice and improved oxidative stress status. More importantly, podophyllotoxin effectively restored the impaired intestinal mucosal barrier function by enhancing the expression of tight junction proteins such as ZO-1 and occludin. Finally, the study revealed that podophyllotoxin may alleviate ulcerative colitis symptoms and promote colonic tissue repair by activating the PI3K/AKT signaling pathway. These findings provide strong experimental evidence for the potential use of podophyllotoxin as a therapeutic agent for ulcerative colitis and offer valuable insights for the future development of ulcerative colitis treatment strategies targeting the PI3K/AKT pathway. Key words: Podophyllotoxin, Ulcerative Colitis, Inflammation, PI3K/AKT.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a ulcerózní kolitida $x farmakoterapie $x chemicky indukované $x metabolismus $x patologie $7 D003093
- 650 12
- $a podofylotoxin $x farmakologie $x terapeutické užití $7 D011034
- 650 12
- $a protoonkogenní proteiny c-akt $x metabolismus $7 D051057
- 650 _2
- $a myši $7 D051379
- 650 12
- $a fosfatidylinositol-3-kinasy $x metabolismus $7 D019869
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a síran dextranu $x toxicita $7 D016264
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Wang, X
- 700 1_
- $a Wang, J
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 74, č. 2 (2025), s. 287-300
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40432443 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20250814 $b ABA008
- 991 __
- $a 20251017095849 $b ABA008
- 999 __
- $a ok $b bmc $g 2413125 $s 1256007
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 74 $c 2 $d 287-300 $e 20250430 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $b NLK191 $a Pubmed-20250814